GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Editors' Picks
Trending World Health OrganizationUSA
Trump’s Move to Ditch the WHO Again: Day 1 Sees a Slew of Executive Orders Signed Off
2025-01-21
JPM 2025 deals
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
JPM 2025 Layoff
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
JPM 2025
JPM 2025 Looks at the Cell and Gene Therapy Landscape – Autoimmune, Cancer, and Chronic Diseases are Front and Center
At JPM 2025, companies like BlueRock Therapeutics, Ginkgo Bioworks, Tune Therapeutics, and Kyverna Therapeutics showcased their advancements in cell and gene therapies. BlueRock is progressing …

Home Read More »

2025-01-21
Asia Pacific APACJapan
$810 Million Turned Into a Rare Disease Revolution with Japan’s Nippon Shinyaku’s and USA’s REGENXBIO’s Partnership
2025-01-21
Special
Trending bird fluUSA
Will U.S. ‘s HHS $590 Million Investment Spark a New Era in mRNA Vaccines for Pandemic Flu Threats?
The U.S. Department of Health and Human Services (HHS) will allocate $590 million to Moderna to develop mRNA-based pandemic influenza vaccines. The funding will also …

Will U.S. ‘s HHS $590 Million Investment Spark a New Era in mRNA Vaccines for Pandemic Flu Threats? Read More »

2025-01-22
JPM 2025
JPM 2025 Looks at the Cell and Gene Therapy Landscape – Autoimmune, Cancer, and Chronic Diseases are Front and Center
At JPM 2025, companies like BlueRock Therapeutics, Ginkgo Bioworks, Tune Therapeutics, and Kyverna Therapeutics showcased their advancements in cell and gene therapies. BlueRock is progressing …

JPM 2025 Looks at the Cell and Gene Therapy Landscape – Autoimmune, Cancer, and Chronic Diseases are Front and Center Read More »

2025-01-21
Technology AI Developments
Building a Virtual Cell with AI: Key Priorities and Opportunities
Experts from Stanford University, Genentech, and the Chan-Zuckerberg Initiative are collaborating to create the virtual human cell, leveraging artificial intelligence (AI). The project aims to …

Building a Virtual Cell with AI: Key Priorities and Opportunities Read More »

2025-01-02
LATEST
Will U.S. ‘s HHS $590 Million Investment Spark a New Era in mRNA Vaccines for Pandemic Flu Threats?
2025-01-22
JPM 2025 Looks at the Cell and Gene Therapy Landscape – Autoimmune, Cancer, and Chronic Diseases are Front and Center
2025-01-21
Trump’s Move to Ditch the WHO Again: Day 1 Sees a Slew of Executive Orders Signed Off
2025-01-21
Cecile Richards’s Battle with Glioblastoma
2025-01-21
$810 Million Turned Into a Rare Disease Revolution with Japan’s Nippon Shinyaku’s and USA’s REGENXBIO’s Partnership
2025-01-21
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
READ MORE
Deals
Funding
Special
Sen-Jam’s First-in-Class FDA-Regulated Hangover Cure Enters Phase 2 Trials
2024-11-20
VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
2024-09-22
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
IPO
Trending
CNS Drug-Maker Reviva Announces $18M Public Offering of Common Stock and Warrants to Fund R&D
2024-12-17
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Galderma’s Strong European IPO Debut
2024-03-26
M&A
JPM 2025 deals
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
The Boldest Business Matchmaking of 2024: A Look at the Top M&A Activity
2025-01-02
Ranking & Reports
Ranking & Reports
Ranking & Reports R&D
2024 EU Industrial R&D Investment Scoreboard Highlights 9.8% Increase in R&D Spending
2024-12-30
Global Trade Wars and Innovation Shake Up the Life Sciences Industry
2024-11-06
Driving Post-Pandemic Growth: Navigating Pricing Pressures and the Rise of Generative AI
2024-11-06
Categories
Interviews
Interviews Regenerative MedicineJapan
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
Asia-Pacific
Healthcare Expo Taiwan 2024 Healthcare Quality Forum
Crossing Borders for a New Era in Medical Service Standards: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
Trials & Approvals
Trials & Approvals Obstructive Sleep Apnea
Eli Lilly’s Zepbound Becomes First and Only FDA Approved Weight Loss Drug to Treat Obstructive Sleep Apnea
2024-12-23
Eli Lilly’s Alzheimer’s Treatment Kisunla Secures Fourth Major Market Approval with NMPA Authorization in China
2024-12-18
Pfizer Pulls Sickle Cell Treatment Over Deadly Complication Risks
2024-09-26
China
Deals Weight Loss Drugsmuscle-preserving
China’s Laekna Joins Forces with Weight-Loss Giant Lilly on Muscle-Preserving Obesity Drug in Expanding $150B Market
2024-11-21
APAC Leading the Industry in Adoptive Cell Therapy – Trials, Economic Growth, and Pioneering Companies
2024-06-24
ArriVent and Alphamab Partner in $615.5 Million Collaboration for Novel ADC Cancer Treatments
2024-06-06 Partner
Startups
Technology Brain-Computer InterfaceNeuroscience
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
Manufacturing
Manufacturing BioNTechAfrica
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
JPMA on Japan’s Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List
2024-10-17
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Licensing
Licensing FDA ApprovalAnaphylaxis
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug
2024-08-12
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
R&D
R&D COVID-19Anti-cancer
COVID Caused Cancer Tumors to Shrink in Mice and We Want to Know How
2025-01-08
Building a Virtual Cell with AI: Key Priorities and Opportunities
2025-01-02
Scanning Some of 2024’s Biggest Medical Breakthroughs
2024-12-31
Technology
Technology AI Developments
Building a Virtual Cell with AI: Key Priorities and Opportunities
2025-01-02
AI-Powered Drug Development: How NVIDIA Builds a Balance Between Biotech and TechBio
2024-12-26
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top